Sheri Biggs sold SINOPHARM GROUP CO LTD ADR (PINK: SHTDY)
Sheri Biggs (R-SC), a U.S. Representative, has disclosed 1 trade in SINOPHARM GROUP CO LTD ADR (SHTDY) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Sheri Biggs sold $1,001 - $15,000 of SINOPHARM GROUP CO LTD ADR (PINK: SHTDY) on March 18, 2025. Since that trade, SHTDY is down -8.20% against the S&P 500 up +31.91%, an outperformance of -40.11%.
Data updated
Sheri Biggs's SHTDY trades vs the price
SHTDY is down -8.20% since Sheri Biggs sold on March 18, 2025, versus +31.91% for the S&P 500.
Performance since this trade
All Sheri Biggs SHTDY trades
Sheri Biggs & SHTDY trading FAQ
Is it legal for Sheri Biggs to trade SINOPHARM GROUP CO LTD ADR (SHTDY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including SINOPHARM GROUP CO LTD ADR (SHTDY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Sheri Biggs sell SHTDY?
Sheri Biggs disclosed a sale of $1,001 - $15,000 of SINOPHARM GROUP CO LTD ADR (SHTDY) on March 18, 2025, according to public STOCK Act filings.
How has SHTDY performed since Sheri Biggs's trade?
Since Sheri Biggs sold SHTDY on March 18, 2025, the stock is down -8.20%, versus +31.91% for the S&P 500 over the same period, an outperformance of -40.11%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SHTDY trades?
Quantellect tracks every disclosed congressional trade in SINOPHARM GROUP CO LTD ADR (SHTDY) on the SINOPHARM GROUP CO LTD ADR congressional trading page, which aggregates filings across all members of Congress.
Sheri Biggs's SHTDY tradesAll congressional filings for SINOPHARM GROUP CO LTD ADRSheri Biggs's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.